SCHEMBL3823955

SCHEMBL3823955

O=C1C=CCN1c1ccc(C(F)(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX4 Q9NPH5 3/20 0.39
HSD11B1 P28845 1/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
PTGS1 P23219 2/20 0.38
PTGS2 P35354 2/20 0.38
GRM2 Q14416 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
MPI P34949 1/20 0.36
PHOSPHO1 Q8TCT1 1/20 0.36
DPP4 P27487 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
AKR1C3 P42330 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12500952 0.78 POLB (0.46) OPRL1
SCHEMBL6392634 0.76 MGLL (0.50) CA2
SCHEMBL23676376 0.76 MGLL (0.60)
SCHEMBL4796187 0.76 FAAH (0.50) GSK3AGSK3BCA12CA9
SCHEMBL1111106 0.75 MEN1 (0.50) GRM2
SCHEMBL20956916 0.73 RAB9A (0.54) NOX4HSD11B1HDAC1HDAC8HDAC6
SCHEMBL27596542 0.71 AR (0.53)
SCHEMBL1364061 0.71 MGLL (0.55) GSK3AGSK3B
SCHEMBL21702652 0.71 VHL (0.40) CA12CA2CA9
SCHEMBL23627343 0.71 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094684-A2 1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN 2-ONES AS CB1 RECEPTOR MODULATORS Eli Lilly & Company (US) 2009-09-02 EP disclosed
WO-2008070306-A2 1,5-DIPHENYL-3-BENZYLAMIN0-1,5-DIHYDR0PYRR0LIDIN-2-0NE AS CB1 RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2008-06-12 WO disclosed